Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
CRO (2)
199 Articles Available
2
9
Can't find what you're looking for? Try our
advanced search
.
Decentralized Clinical Trials
A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research
PAO-10-21-CL-04
Clinical Supply
Integrating a Personal Approach to Clinical Supply Services
PAO-09-21-CL-08
Early Development Studies
Complex Early Development Studies — Managing FIH to Phase Ib
PAO-08-21-CL-04
M&A
Thermo Fisher Scientific Acquires PPD and Leverages Clinical
PAO-06-21-MA-01
Clinical Trials
Keeping Clinical Trials Running During a Pandemic
PAO-04-22-R221-56
M&A
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
M&A
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
PR-M04-21-016
The Future of Healthcare
How Does SanaClis Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-014
Decentralized Trials
Facilitating the Full Spectrum of Decentralized Trials
PAP-Q3-20-CL-009
Decentralized Trials
Protecting Clinical Research and Patients Through Decentralized Trial Strategies
PAP-Q3-20-CL-025
Bioanalysis
How Bioanalysis Supports the Development of New Cell and Gene Therapies
PAP-Q3-20-CL-012
The Future of Healthcare
How Is Sanaclis Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-010
Research Innovation
Leveraging Innovative Technologies to Access Better Data More Efficiently and Cost-Effectively
PAP-Q2-20-CL-010
The Future of Healthcare
How is SanaClis Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
PAP-Q2-20-RT2-011
Coronavirus
BioPharma Services Inc. Donates its Clinical Resources and Scientific Expertise in the Pursuit of Coronavirus COVID-19 Vaccine Research
PR-M03-20-NI-006
CRO
Bayer and Nuvisan Create New Research Unit in Berlin
PR-M02-20-NI-013
M&A
Synteract Expands into Asia Pacific and South Africa Through Acquisition of Specialty Biometrics CRO
PR-M02-20-NI-005
Biosimilars
Accelerating Biosimilar Development
PAP-Q1-2019-CL-014
Drug Discovery
A Research Partner With Proven Results
PAP-Q1-2019-CL-038
Acquisition
Optimapharm Acquires Swiss Denothex and Becomes a Leading European Mid-size Clinical Research Organization
PR-M02-19-NI-016
CRO
From Internal Lab to External Service Provider
PAO-M08-18-NI-009
Opening
DPS Group and TRIA Celebrate Opening of State-of-the-Art cGMP mRNA Clinical Manufacturing Facility for Moderna Therapeutics
PR-M07-18-NI-077
CRO
Optimapharm, Europe’s fast-growing CRO, expands office network to the United Kingdom
PR-M07-18-NI-077
Expansion
Optimapharm, Europe’s fast-growing CRO, expands office network to US and Hungary
PR-M06-18-NI-035
«
2
9
»
.svg)
